Health Professionals News
Meeting addresses vital role of MS nurses
12 March 2010
The MS nurses specialists annual meeting that took place recently in York stressed the importance of the role for people with multiple sclerosis.
Multiple Sclerosis Annual Evidence Update now available
08 March 2010
NHS Evidence Annual Evidence Updates (AEUs) attempt to draw together recently published, high quality evidence - focusing particularly on systematic reviews and published guidelines - which it is hoped will inform and enhance the decision making and planning of clinicians, commissioners and others involved in the process of health care.
MS Trust supports RCN's call for more investment in specialist nurses
24 February 2010
The MS Trust supports the call by the Royal College of Nursing (RCN) for greater investment in specialist nurses to support people with long-term conditions such as multiple sclerosis (MS).
Vitamin D - the latest information
18 February 2010
With much data being published recently about the influence of sunlight and vitamin D on the incidence of MS the MS Trust has produced a new factsheet summarising the latest information.
MS Trust comments on new data on CCSVI
12 February 2010
Preliminary results from a study of CCSVI report an association with people with MS.
MP calls for abolition of the MS drugs risk-sharing scheme
08 February 2010
The Risk-sharing Scheme, the mechanism that makes disease modifying drugs for MS available on the NHS, was debated in Parliament on 2 February.
Lifetime award for MS care
02 February 2010
Neurological specialist nurse Lynda Hind was given the first Multiple Sclerosis Trust lifetime achievement award.
Exciting new exercise resource launched for people with MS
01 February 2010
Following the success of the book Exercises for people with MS, the MS Trust has launched a new set of web pages full of exercises for people with MS.
More oral MS drug research results published
26 January 2010
Research published in the New England Journal of Medicine (NEJM) suggests that the oral drug cladribine reduces relapse rates and disease progression in people with relapsing remitting MS.
Tysabri labelling changes recommended
22 January 2010
The European Medicines Agency has recommended new measures for dealing with the risks associated with the drug natalizumab (Tysabri).
Oral MS drug research results published
21 January 2010
Research published online today in the New England Journal of Medicine (NEJM) suggests the new oral drug fingolimod may be more effective than current disease modifying drugs for MS.
Revised ABN guidelines published
23 December 2009
At long last the new Association of British Neurologists (ABN) revised (2009) guidelines for prescribing disease modifying drugs in multiple sclerosis have been published.
